Ribomic Inc

NEW
TSE:4591 (Japan)  
円 59 +1 (+1.72%) Jun 26
At Loss
P/B:
1.13
Market Cap:
円 3.30B ($ 20.65M)
Enterprise V:
円 473.80M ($ 2.96M)
Volume:
152.60K
Avg Vol (2M):
540.56K
Trade In:
Volume:
152.60K
At Loss

Business Description

Description
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.96
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
13.03
Distress
Grey
Safe
Beneish M-Score
-1.18
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
38.32
9-Day RSI
35.25
14-Day RSI
33.86
3-1 Month Momentum %
-24.21
6-1 Month Momentum %
-4
12-1 Month Momentum %
-29.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
21.68
Quick Ratio
21.66
Cash Ratio
20.93
Days Sales Outstanding
67.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-15
Shareholder Yield %
-27.92

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin %
-40237.73
Net Margin %
-38178.67
EBITDA Margin %
-40104.57
FCF Margin %
-37367.67
OCF Margin %
-37028.77
ROE %
-37.67
ROA %
-36.06
ROIC %
-1367.79
3-Year ROIIC %
-4342.9
ROC (Joel Greenblatt) %
-12339.92
ROCE %
-39.7

GF Valueâ„¢

Ribomic Inc Filings

Filing Date Document Date Form
No Filing Data

Ribomic Inc Stock Events

Financials Calendars
Event Date Price (円)
No Event Data

Press Release

Subject Date
No Press Release

Articles on Ribomic Inc

No articles.